Eye Therapies, LLC: Clinical Trials

3 trials sponsored by Eye Therapies, LLC, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 2 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2
Phase 11Completed 1

Follow Eye Therapies, LLC: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study Evaluating the Safety and Intraocular Pressure (IOP) Lowering Response of Brimonidine Tartrate Ophthalmic Solution in Subjects With Open Angle Glaucoma or Ocular Hypertension
Brimonidine Tartrate 0.025%, Vehicle - Glaucoma and Ocular Hypertension
Phase 1CompletedEye Therapies, LLC152012-09-012012-12-25
Study Evaluating the Safety and Efficacy of Brimonidine Tartrate Ophthalmic Solution in Adult and Geriatric Subjects
Placebo, Brimonidine tartrate 0.025% - Ocular Redness
Phase 2CompletedEye Therapies, LLC572012-08-012014-07-31
A Single-Center, Randomized, Double-Masked, Placebo and Active Controlled, Dose-Ranging Evaluation of the Duration of Action of Brimonidine Tartrate Ophthalmic Solution in the Control of Ocular Redness Induced by Conjunctival Allergen Challenge (CAC)
Vehicle, Brimonidine Tartrate 0.01%, Brimonidine Tartrate 0.025% - Allergic Conjunctivitis
Phase 2CompletedEye Therapies, LLC682011-01-012012-03-06

Conditions studied

Conjunctivitis, Allergic (1)  ·  Glaucoma (1)  ·  Ocular Hypertension (1)

Countries

United States (3)